| Carol Bennett, MA CCC | |
|
205 E B St, Jenks, OK 74037-3906 | |
| (918) 299-4411 | |
| Not Available |
| Full Name | Carol Bennett |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 205 E B St, Jenks, Oklahoma |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033344783 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 997 (Oklahoma) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Carol Bennett, MA CCC 205 E B St, Jenks, OK 74037-3906 Ph: (918) 299-4411 | Carol Bennett, MA CCC 205 E B St, Jenks, OK 74037-3906 Ph: (918) 299-4411 |
News Archive
BioImagene, Inc., the leading provider of innovative digital pathology solutions, launched Crescendo – the new Digital Pathology Workstation (DPW) at the CAP '09 – THE Pathologists' Meeting™. The meeting is taking place from October 11 - 14, 2009 in the Gaylord National Harbor in Washington D.C.
Boehringer Ingelheim today announced overall survival (OS) results from the LUX-Lung 8 trial (NCT01523587) that directly compared the efficacy and safety of two EGFR-directed treatments, afatinib and erlotinib, in patients with advanced squamous cell carcinoma (SCC) of the lung, progressing after treatment with first-line chemotherapy. Treatment with afatinib significantly reduced the risk of death by 19%, extending the survival of patients to a median of 7.9 months compared to 6.8 months on erlotinib.
Over the years, hunting for cancer-related genes and understanding how they work has been an important, although time-consuming, exercise.
The invasion and spread of cancer cells to other parts of the body, known as metastasis, is a principal cause of death in patients diagnosed with breast cancer. Although patients with early stage, small, breast tumours have an excellent short term prognosis, more than 15 to 20 per cent of them will eventually develop distant metastases, and die from the disease. Vascular invasion - through lymphatic and blood vessels - is the major route for cancer spreading to regional lymph nodes and to the rest of the body.
› Verified 8 days ago
Mr. Lynette Rae Acebo, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 510 N Douglas St, Jenks, OK 74037 Phone: 918-645-3020 Fax: 918-298-5336 | |
Mrs. Kristie Kaye Shoemake, M.A., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 11716 S Willow Pl, Jenks, OK 74037 Phone: 918-520-4304 | |
Paige Allyson Grant, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1911 W C St, Jenks, OK 74037 Phone: 918-409-0157 | |
1st Choice Therapy Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 12120 S 2nd St, Jenks, OK 74037 Phone: 918-808-9749 | |
Montana Barham, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 240 S Adams St, Jenks, OK 74037 Phone: 918-409-0157 Fax: 918-209-4788 | |
Mrs. Elizabeth Ellen Howard, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 915 N Ivy St, Jenks, OK 74037 Phone: 918-299-5379 |